Badarch Uranchimeg

2.6k total citations · 1 hit paper
17 papers, 2.2k citations indexed

About

Badarch Uranchimeg is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Badarch Uranchimeg has authored 17 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Badarch Uranchimeg's work include Cancer, Hypoxia, and Metabolism (12 papers), Angiogenesis and VEGF in Cancer (4 papers) and Cancer-related Molecular Pathways (3 papers). Badarch Uranchimeg is often cited by papers focused on Cancer, Hypoxia, and Metabolism (12 papers), Angiogenesis and VEGF in Cancer (4 papers) and Cancer-related Molecular Pathways (3 papers). Badarch Uranchimeg collaborates with scholars based in United States, Italy and Argentina. Badarch Uranchimeg's co-authors include Giovanni Melillo, Annamaria Rapisarda, Robert H. Shoemaker, Dominic A. Scudiero, Edward A. Sausville, Luca Vago, Alessandra Saccani, Andrea Doni, Antonio Sica and Sergio Bernasconi and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Badarch Uranchimeg

17 papers receiving 2.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regulation of the Chemokine Receptor CXCR4 by Hypoxia

2003 671 citations Tiziana Schioppa, Badarch Uranchimeg et al. The Journal of Experimental Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Badarch Uranchimeg United States	14	1.2k	1.1k	666	486	185	17	2.2k
Luana Schito Canada	19	1.1k 1.0×	1.2k 1.0×	646 1.0×	328 0.7×	204 1.1×	23	2.2k
Mei Yee Koh United States	19	1.3k 1.1×	1.5k 1.3×	379 0.6×	223 0.5×	259 1.4×	26	2.3k
Levi J. Beverly United States	28	1.7k 1.5×	403 0.4×	601 0.9×	345 0.7×	163 0.9×	65	2.7k
Theresa LaVallee United States	22	1.4k 1.2×	745 0.7×	722 1.1×	306 0.6×	275 1.5×	57	2.4k
Lin Pei United States	24	1.3k 1.1×	478 0.4×	488 0.7×	396 0.8×	217 1.2×	48	2.6k
Andrea Morandi Italy	29	1.7k 1.4×	1.4k 1.2×	787 1.2×	389 0.8×	429 2.3×	49	2.9k
Carla P. Martins United Kingdom	19	2.0k 1.7×	611 0.5×	1.4k 2.1×	531 1.1×	252 1.4×	25	3.1k
Susanne Sebens Müerköster Germany	26	1.4k 1.2×	580 0.5×	1.2k 1.8×	697 1.4×	122 0.7×	34	2.6k
Margaret Willard United States	10	1.0k 0.9×	719 0.6×	438 0.7×	327 0.7×	172 0.9×	12	1.7k
Dawn A. Kirschmann United States	29	2.6k 2.2×	1.0k 0.9×	1.2k 1.8×	409 0.8×	325 1.8×	39	3.4k

Countries citing papers authored by Badarch Uranchimeg

Since Specialization

Citations

This map shows the geographic impact of Badarch Uranchimeg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Badarch Uranchimeg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Badarch Uranchimeg more than expected).

Fields of papers citing papers by Badarch Uranchimeg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Badarch Uranchimeg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Badarch Uranchimeg. The network helps show where Badarch Uranchimeg may publish in the future.

Co-authorship network of co-authors of Badarch Uranchimeg

This figure shows the co-authorship network connecting the top 25 collaborators of Badarch Uranchimeg. A scholar is included among the top collaborators of Badarch Uranchimeg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Badarch Uranchimeg. Badarch Uranchimeg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Rahman, Khondaker Miraz, Badarch Uranchimeg, Dyeison Antonow, et al.. (2014). Tetracycline analogues with a selective inhibitory effect on HIF-1α. MedChemComm. 5(7). 923–923. 3 indexed citations

Terzuoli, Erika, Maura Puppo, Annamaria Rapisarda, et al.. (2010). Aminoflavone, a Ligand of the Aryl Hydrocarbon Receptor, Inhibits HIF-1α Expression in an AhR-Independent Fashion. Cancer Research. 70(17). 6837–6848. 95 indexed citations

Rapisarda, Annamaria, Melinda G. Hollingshead, Badarch Uranchimeg, et al.. (2009). Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition. Molecular Cancer Therapeutics. 8(7). 1867–1877. 136 indexed citations

Tandle, Anita, Maura Calvani, Badarch Uranchimeg, et al.. (2009). Endothelial monocyte activating polypeptide-II modulates endothelial cell responses by degrading hypoxia-inducible factor-1alpha through interaction with PSMA7, a component of the proteasome. Experimental Cell Research. 315(11). 1850–1859. 30 indexed citations

Zhou, Qin, Dominic A. Scudiero, Badarch Uranchimeg, et al.. (2009). Cytotoxic and HIF-1α Inhibitory Compounds from Crossosoma bigelovii. Journal of Natural Products. 72(5). 805–812. 18 indexed citations

McCloud, Thomas G., Badarch Uranchimeg, Giovanni Melillo, et al.. (2008). Separation and SAR Study of HIF-1α Inhibitory Tubulosines from Alangium cf. longiflorum. Planta Medica. 74(3). 258–263. 13 indexed citations

Trisciuoglio, Daniela, Badarch Uranchimeg, John H. Cardellina, et al.. (2008). Induction of Apoptosis in Human Cancer Cells by Candidaspongiolide, a Novel Sponge Polyketide. JNCI Journal of the National Cancer Institute. 100(17). 1233–1246. 33 indexed citations

Cardellina, John H., Andrew G. Stephen, Annamaria Rapisarda, et al.. (2007). Cell Type–Specific, Topoisomerase II–Dependent Inhibition of Hypoxia-Inducible Factor-1α Protein Accumulation by NSC 644221. Clinical Cancer Research. 13(3). 1010–1018. 45 indexed citations

Iribarren, Pablo, Keqiang Chen, Wanghua Gong, et al.. (2007). Interleukin 10 and TNFα synergistically enhance the expression of the G protein-coupled formylpeptide receptor 2 in microglia. Neurobiology of Disease. 27(1). 90–98. 10 indexed citations

10.

Kim, Young Ho, et al.. (2006). Crinamine from Crinum asiaticum var. japonicum Inhibits Hypoxia Inducible Factor-1 Activity But Not Activity of Hypoxia Inducible Factor-2. Biological and Pharmaceutical Bulletin. 29(10). 2140–2142. 20 indexed citations

11.

Calvani, Maura, et al.. (2006). Related citationsHypoxic induction of an HIF-1alpha-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells.. Florence Research (University of Florence). 2705–2712. 28 indexed citations

12.

Iribarren, Pablo, Keqiang Chen, Jinyue Hu, et al.. (2005). CpG‐containing oligodeoxynucleotide promotes microglial cell uptake of amyloid β 1–42 peptide by up‐regulating the expression of the G‐protein‐coupled receptor mFPR2. The FASEB Journal. 19(14). 2032–2034. 78 indexed citations

13.

Calvani, Maura, Annamaria Rapisarda, Badarch Uranchimeg, Robert H. Shoemaker, & Giovanni Melillo. (2005). Hypoxic induction of an HIF-1α–dependent bFGF autocrine loop drives angiogenesis in human endothelial cells. Blood. 107(7). 2705–2712. 199 indexed citations

14.

Rapisarda, Annamaria, Melinda G. Hollingshead, Till Braunschweig, et al.. (2004). Schedule-dependent Inhibition of Hypoxia-inducible Factor-1α Protein Accumulation, Angiogenesis, and Tumor Growth by Topotecan in U251-HRE Glioblastoma Xenografts. Cancer Research. 64(19). 6845–6848. 162 indexed citations

15.

Rapisarda, Annamaria, Badarch Uranchimeg, Olivier Sordet, et al.. (2004). Topoisomerase I-Mediated Inhibition of Hypoxia-Inducible Factor 1. Cancer Research. 64(4). 1475–1482. 256 indexed citations

16.

Schioppa, Tiziana, Badarch Uranchimeg, Alessandra Saccani, et al.. (2003). Regulation of the Chemokine Receptor CXCR4 by Hypoxia. The Journal of Experimental Medicine. 198(9). 1391–1402. 671 indexed citations breakdown →

17.

Rapisarda, Annamaria, Badarch Uranchimeg, Dominic A. Scudiero, et al.. (2002). Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.. PubMed. 62(15). 4316–24. 397 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact